1. Home
  2. CHYM vs PEN Comparison

CHYM vs PEN Comparison

Compare CHYM & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chime Financial Inc.

CHYM

Chime Financial Inc.

N/A

Current Price

$32.41

Market Cap

12.0B

Sector

Finance

ML Signal

N/A

Logo Penumbra Inc.

PEN

Penumbra Inc.

N/A

Current Price

$319.92

Market Cap

12.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHYM
PEN
Founded
2012
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
12.7B
IPO Year
2025
2015

Fundamental Metrics

Financial Performance
Metric
CHYM
PEN
Price
$32.41
$319.92
Analyst Decision
Strong Buy
Hold
Analyst Count
23
17
Target Price
$42.38
★ $362.54
AVG Volume (30 Days)
★ 4.7M
372.8K
Earning Date
11-04-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1155.56
EPS
0.31
★ 2.77
Revenue
★ $2,186,770,000.00
$1,403,665,000.00
Revenue This Year
$28.06
$14.38
Revenue Next Year
$23.18
$12.84
P/E Ratio
★ $106.23
$115.23
Revenue Growth
★ 30.69
17.50
52 Week Low
$15.88
$277.54
52 Week High
$35.55
$362.41

Technical Indicators

Market Signals
Indicator
CHYM
PEN
Relative Strength Index (RSI) 57.45 46.99
Support Level $30.95 $315.83
Resistance Level $33.41 $320.08
Average True Range (ATR) 1.37 2.45
MACD 0.27 -0.26
Stochastic Oscillator 66.43 23.52

Price Performance

Historical Comparison
CHYM
PEN

About CHYM Chime Financial Inc.

Chime Financial Inc is a financial technology company that provides digital banking services through its proprietary technology platform in partnership with third-party banks. The company offers various financial products and services designed to meet members' financial needs, including spending accounts, liquidity solutions, credit-building tools, savings products, and community-focused financial services.

About PEN Penumbra Inc.

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Share on Social Networks: